Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer (HERCULES)
Condition:   Penile Carcinoma Interventions:   Drug: Pembrolizumab;   Drug: Standard of care therapy Sponsors:   Latin American Cooperative Oncology Group;   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2020 Category: Research Source Type: clinical trials

Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
Condition:   Penile Squamous Cell Carcinoma Intervention:   Drug: Cabozantinib Sponsor:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2019 Category: Research Source Type: clinical trials